当前位置:首页 > WHO世界卫生组织 >

WHO世界卫生组织:2023年结核病儿科药物优化会议报告(英文版)

  • 2024年06月05日
  • 50 金币

Paediatric drug optimization (PADO) exercises have been convened by the World Health Organization (WHO) for various diseases, demonstrating their potential and impact to accelerate access to optimal formulations in the context of fragmented small markets for medicines for children. The WHO Global Tuberculosis Programme has convened PADO-TB meetings since February 2019 (PADO-TB1), followed by an interim review of the PADO-TB1 priorities in September 2020.

Optimization of paediatric TB me

  • 关注微信

猜你喜欢